Aethlon Book Value Per Share vs Roic Analysis

Stocks . USA . 
Stock . Aethlon Medical
AEMD Stock  USD 0.37  0  0.27%   
Aethlon Medical financial indicator trend analysis is way more than just evaluating Aethlon Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aethlon Medical is a good investment. Please check the relationship between Aethlon Medical Book Value Per Share and its Roic accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Book Value Per Share vs Roic

Book Value Per Share vs Roic Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aethlon Medical Book Value Per Share account and Roic. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Aethlon Medical's Book Value Per Share and Roic is -0.41. Overlapping area represents the amount of variation of Book Value Per Share that can explain the historical movement of Roic in the same time period over historical financial statements of Aethlon Medical, assuming nothing else is changed. The correlation between historical values of Aethlon Medical's Book Value Per Share and Roic is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value Per Share of Aethlon Medical are associated (or correlated) with its Roic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Roic has no effect on the direction of Book Value Per Share i.e., Aethlon Medical's Book Value Per Share and Roic go up and down completely randomly.

Correlation Coefficient

-0.41
Relationship DirectionNegative 
Relationship StrengthVery Weak

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.
Most indicators from Aethlon Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.01, whereas Sales General And Administrative To Revenue is forecasted to decline to 6.30.

Aethlon Medical fundamental ratios Correlations

Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Other Stockholder Equity
Total Liab
Total Current Assets
Common Stock
Property Plant And Equipment Net
Accounts Payable
Property Plant And Equipment Gross
Intangible Assets
Short Long Term Debt Total
Current Deferred Revenue
Other Assets
Net Receivables
Inventory
Other Current Assets
Total Assets
-0.27-0.340.86-0.97-0.740.970.650.450.97-0.40.680.79-0.30.97-0.380.68-0.070.56-0.77-0.36-0.4-0.06-0.32-0.840.19
Other Current Liab
-0.270.94-0.70.390.23-0.27-0.17-0.17-0.270.93-0.22-0.330.95-0.260.92-0.190.33-0.180.450.680.85-0.030.190.29-0.1
Total Current Liabilities
-0.340.94-0.770.490.27-0.35-0.16-0.15-0.350.98-0.21-0.371.0-0.340.97-0.190.48-0.170.530.860.960.070.360.32-0.14
Total Stockholder Equity
0.86-0.7-0.77-0.92-0.650.850.520.390.85-0.80.580.74-0.740.84-0.780.56-0.30.47-0.81-0.71-0.79-0.07-0.4-0.760.21
Net Debt
-0.970.390.49-0.920.67-0.98-0.5-0.31-0.980.52-0.55-0.730.46-0.970.5-0.540.25-0.410.740.550.550.060.340.8-0.26
Retained Earnings
-0.740.230.27-0.650.67-0.64-0.74-0.7-0.640.34-0.78-0.990.22-0.640.36-0.73-0.04-0.720.650.320.410.620.430.8-0.1
Cash
0.97-0.27-0.350.85-0.98-0.640.470.241.0-0.380.510.69-0.331.0-0.350.52-0.180.37-0.66-0.39-0.4-0.01-0.24-0.770.24
Non Current Assets Total
0.65-0.17-0.160.52-0.5-0.740.470.90.47-0.260.960.76-0.10.47-0.271.00.40.99-0.82-0.1-0.25-0.13-0.52-0.72-0.1
Non Currrent Assets Other
0.45-0.17-0.150.39-0.31-0.70.240.90.24-0.250.930.72-0.090.25-0.290.870.450.95-0.75-0.13-0.25-0.27-0.5-0.63-0.15
Cash And Short Term Investments
0.97-0.27-0.350.85-0.98-0.641.00.470.24-0.380.510.69-0.331.0-0.350.52-0.180.37-0.66-0.39-0.4-0.01-0.24-0.770.24
Common Stock Total Equity
-0.40.930.98-0.80.520.34-0.38-0.26-0.25-0.38-0.32-0.450.97-0.381.0-0.280.47-0.270.590.820.970.090.340.41-0.14
Common Stock Shares Outstanding
0.68-0.22-0.210.58-0.55-0.780.510.960.930.51-0.320.81-0.160.51-0.340.950.380.96-0.85-0.2-0.31-0.15-0.5-0.82-0.1
Other Stockholder Equity
0.79-0.33-0.370.74-0.73-0.990.690.760.720.69-0.450.81-0.320.68-0.460.75-0.010.74-0.73-0.4-0.5-0.56-0.46-0.830.12
Total Liab
-0.30.951.0-0.740.460.22-0.33-0.1-0.09-0.330.97-0.16-0.32-0.310.96-0.130.49-0.110.480.850.950.040.310.3-0.16
Total Current Assets
0.97-0.26-0.340.84-0.97-0.641.00.470.251.0-0.380.510.68-0.31-0.340.52-0.170.37-0.65-0.37-0.38-0.01-0.22-0.770.23
Common Stock
-0.380.920.97-0.780.50.36-0.35-0.27-0.29-0.351.0-0.34-0.460.96-0.34-0.290.44-0.290.60.820.970.120.350.41-0.13
Property Plant And Equipment Net
0.68-0.19-0.190.56-0.54-0.730.521.00.870.52-0.280.950.75-0.130.52-0.290.370.97-0.84-0.13-0.27-0.08-0.53-0.73-0.08
Accounts Payable
-0.070.330.48-0.30.25-0.04-0.180.40.45-0.180.470.38-0.010.49-0.170.440.370.42-0.060.50.540.230.1-0.05-0.21
Property Plant And Equipment Gross
0.56-0.18-0.170.47-0.41-0.720.370.990.950.37-0.270.960.74-0.110.37-0.290.970.42-0.81-0.12-0.26-0.17-0.54-0.68-0.1
Intangible Assets
-0.770.450.53-0.810.740.65-0.66-0.82-0.75-0.660.59-0.85-0.730.48-0.650.6-0.84-0.06-0.810.520.61-0.010.680.82-0.04
Short Long Term Debt Total
-0.360.680.86-0.710.550.32-0.39-0.1-0.13-0.390.82-0.2-0.40.85-0.370.82-0.130.5-0.120.520.90.240.470.39-0.27
Current Deferred Revenue
-0.40.850.96-0.790.550.41-0.4-0.25-0.25-0.40.97-0.31-0.50.95-0.380.97-0.270.54-0.260.610.90.230.480.42-0.15
Other Assets
-0.06-0.030.07-0.070.060.62-0.01-0.13-0.27-0.010.09-0.15-0.560.04-0.010.12-0.080.23-0.17-0.010.240.230.20.15-0.18
Net Receivables
-0.320.190.36-0.40.340.43-0.24-0.52-0.5-0.240.34-0.5-0.460.31-0.220.35-0.530.1-0.540.680.470.480.20.440.22
Inventory
-0.840.290.32-0.760.80.8-0.77-0.72-0.63-0.770.41-0.82-0.830.3-0.770.41-0.73-0.05-0.680.820.390.420.150.44-0.17
Other Current Assets
0.19-0.1-0.140.21-0.26-0.10.24-0.1-0.150.24-0.14-0.10.12-0.160.23-0.13-0.08-0.21-0.1-0.04-0.27-0.15-0.180.22-0.17
Click cells to compare fundamentals

Aethlon Medical Account Relationship Matchups

High Positive Relationship

Total Liab
+ 1.0
Total Current Liabilities
Cash And Short Term Investments
+ 1.0
Cash
Total Current Assets
+ 1.0
Cash
Property Plant And Equipment Net
+ 1.0
Non Current Assets Total
Total Current Assets
+ 1.0
Cash And Short Term Investments
Common Stock
+ 1.0
Common Stock Total Equity

High Negative Relationship

Other Stockholder Equity
- 0.99
Retained Earnings
Cash And Short Term Investments
- 0.98
Net Debt
Cash
- 0.98
Net Debt
Total Current Assets
- 0.97
Net Debt
Net Debt
- 0.97
Total Assets
Net Debt
- 0.92
Total Stockholder Equity

Aethlon Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets10.4M10.7M19.4M17.5M8.2M8.7M
Other Current Liab584.1K880.2K852.6K802.8K761.5K723.4K
Total Current Liabilities1.1M1.4M1.8M1.5M1.8M2.8M
Total Stockholder Equity9.4M9.4M17.1M15.1M5.8M6.1M
Net Debt(9.5M)(9.8M)(16.3M)(13.3M)(4.5M)(4.3M)
Retained Earnings(112.0M)(119.9M)(130.3M)(142.4M)(154.6M)(146.8M)
Cash9.6M9.9M17.1M14.5M5.4M3.0M
Non Current Assets Total346.6K317.2K1.3M2.4M2.3M2.4M
Cash And Short Term Investments9.6M9.9M17.1M14.5M5.4M3.0M
Common Stock Total Equity17.7K19.0K9.4K12.2K14.0K13.3K
Common Stock Shares Outstanding341.5K1.2M1.5M2.1M2.5M2.6M
Liabilities And Stockholders Equity10.4M10.7M19.4M17.5M8.2M8.7M
Other Stockholder Equity121.4M129.3M147.4M157.4M160.3M168.4M
Total Liab1.1M1.4M2.4M2.4M2.5M4.1M
Total Current Assets10.0M10.4M18.2M15.1M5.9M3.2M
Common Stock9.4K12.2K15.4K23.0K2.6K2.5K
Property Plant And Equipment Net276.9K201.3K1.1M2.3M1.9M2.0M
Accounts Payable285.0K337.7K500.0K432.9K777.9K566.0K
Property Plant And Equipment Gross276.9K201.3K1.1M2.3M2.9M3.0M
Intangible Assets57.5K57.0K2.2K1.7K1.1K1.0K
Short Long Term Debt Total141.1K42.5K729.4K1.2M940.3K949.8K
Other Current Assets229.6M341.1K1.9M557.6K506.0K480.7K
Accumulated Other Comprehensive Income(368.3K)(385.5K)0.0(6.1M)(6.9K)(7.3K)
Short Term Debt98.6K42.5K126.9K269.4K290.6K276.0K
Property Plant Equipment140.5K201.3K1.1M2.3M2.6M2.8M
Non Current Liabilities Total42.5K495.1K602.5K939.6K649.8K544.9K
Net Tangible Assets9.4M9.4M17.1M15.1M17.3M18.2M
Noncontrolling Interest In Consolidated Entity(101.2K)(126.0K)(132.1K)(136.9K)(123.2K)(117.1K)
Retained Earnings Total Equity(99.5M)(105.7M)(112.0M)(119.9M)(107.9M)(113.3M)
Capital Surpluse105.6M108.1M121.4M129.3M148.7M97.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:
How To Invest In Aethlon
Details
Is Aethlon Stock a good investment?
Details
What is Aethlon Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Revenue Per Share
0.236
Quarterly Revenue Growth
42.782
Return On Assets
(0.50)
Return On Equity
(1.05)
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY